Tao Wang,Zhongxing Zhang,Ying Han,Zhiwei Yin,Paul Michael Scola
申请号：
US14762542
公开号：
US09655902B2
申请日:
2014.01.23
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
